Our expertise lies in nucleic acid extraction systems, passive cooling, and heating blocks, as well as liquid handling systems and modules such as sample cooling & heating modules, shaking, and liquid automation. All provided products are designed and manufactured in-house. We are dedicated to only producing top-quality parts at the highest standards under ISO 9001 directives. We are working with the experts and among our references, we have Omega Bio-Tek, Johnson & Johnson, Abcam, and BPS BioScience
ÄIO replaces unsustainable fats and oils with high-quality microbial alternatives. For instance, we can replace palm oil or coconut fat in any food without changing its texture, taste or quality. Or just a tiny amount of ÄIO’s microbial oil substitute can make a huge difference in your cosmetics functioning. ÄIO values regional production and the reuse of low-value by-products. Upcycling them by fermentation results in high-value ingredients with reduced carbon footprint. With our production process and technology, we want to reimagine how we produce and consume, to build new value chains and create a more reliable future. Most importantly, we’re not afraid to push the boundaries of what’s possible to make it happen.
Science-based development of dairy products from raw materials to final formulations along the entire value chain. Nutritional profiling (including sugars, salt, fat, etc.) of different representatives of food groups in quantities not undesirable to health. Increasing protein and/or fibre content to levels positively affecting the human metabolism. Enriching food products with minerals and vitamins that help with current health problems. Soy- and gluten-free products. Products free from other allergenic components, if necessary. Development of science-based organic products and clean label. Creating compositions Applied and development research Retention tests Functional food health effects studies with different experimental schemes, We make compositions. We manufacture prototype products. We carry out prototype product stability and quality testing. We carry out clinical trials to prove the health-promoting properties of the products.
Institute of Technology at the University of Tartu has been focusing on offering services to public and private sector in Infection Biology and Drug Screening fields. We have in-house capabilities to take drug development process through preclinical stages. We can be your partner in funding applications and provide scientific expertise.
Liane Viru
Administrative Head of the Core Biosafety Laboratory
+372 5343 6585
[email protected] LinkedInBioatlas has focused on the development of reagents for agarose gel electrophoresis more than 15 years. Our main goal is to make agarose gel preparation easier and safer. Our safe DNA stains and patented tablet technology are already introduced to many countries and numerous institutions, including educational system in USA.
Icosagen, a leading CRDMO for the biopharmaceutical, biotechnology, and diagnostic industries, was founded in 1999. In 2022, we worked with 100+ companies, producing 3000+ proteins. Our seamless services include early clinical candidate development and stable CHO cell line development for 50L to 1000L GMP production runs. Clients trust us for custom-tailored solutions in every stage of drug development, from complicated protein discovery to recombinant production.
Connected Health, founded by the Science Park Tehnopol, is a country-wide partnership between health-related stakeholders in Estonia, who are committed to accelerating the adoption of connected health solutions, on an international scale and on commercial terms. The cluster brings together 80+ partners, including 43 companies (start-ups, health IT, medtech, biotech, and pharma), R&D partners (universities and technology competence centres), health and wellness service providers (hospitals, GPs, occupational health, spas, fitness and sports), patient organisations and user communities, and public sector (ministries responsible for healthcare and entrepreneurship, national health insurance, and the national health development agency).
05 Jun 2023
Boston, USA